Compact, cost-effective, and operator-friendly fundus camera for early detection
Compact, cost-effective, and operator-friendly fundus camera for early detection
批准号:
8394504
负责人:
Filipp Ignatovich
金额:
$49.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-04-01 至 2014-08-31
关键词:
AddressAgeAlgorithmsAutomationBackBlindnessCaringChildhoodChronic CareClinicalCommunitiesComputersCorneaDiagnosisEarly DiagnosisElectronicsEnsureEquilibriumExhibitsEyeEye diseasesFundingFundusGoalsHandHealthHealth Care CostsHealth PersonnelHospitalsHousingHumanImageImage AnalysisImageryInternal MedicineLaboratoriesLegal patentMarketingMechanicsMedicalMedical DeviceMethodologyMethodsMilitary PersonnelMiniaturizationNursing HomesOphthalmoscopesOptic NerveOpticsOptometryOutcomePatientsPerformancePhasePopulationPrevalencePrimary Health CarePrisonsProceduresProcessProviderQuality of lifeRetinaRetinalRiskScanningScheduleServicesSignal TransductionSmall Business Innovation Research GrantSpecialistStagingSystemTechnologyTestingTrainingTreatment outcomeVeteransVisitVisualVisual impairmentWireless Technologybasebrasscostcost effectivedesigndigitaldisabilitydisease diagnosisergonomicsimprovedinnovationinstrumentmanufacturing process developmentmeetingsminiaturizeoptic nerve disorderportabilityprogramsprototypesuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This SBIR application will revolutionize the methodology for routine examination of the back of the eye by developing an easy-to-use, pocket-sized, inexpensive digital camera for documenting retinal and optic nerve diseases. In order to reduce rates of preventable vision loss, the early diagnosis of treatable eye diseases has become increasingly important, especially as the global population ages. Early disease diagnosis is vital to preserving retinal and optic nerve function. The widely available direct ophthalmoscope is used routinely but only with difficulty. It has a small field of view, provides a
fleeting image and leaves no examination record. Although ground-breaking when it was invented in the mid-19th century, this instrument is no longer a cutting edge tool in global effort to reduce vision loss. Traditional fundus cameras are a valuable technology, but they are expensive and bulky, and are typically used by trained technicians in well funded eye care centers. As a result, a lack of a quality retinal examination puts many people at risk for vision loss. Housed in a small ergonomic design, the new camera drastically simplifies fundus imaging. Quality photographs are obtained by bringing the smooth front tip of the camera into brief contact with a patient's anesthetized cornea. Image acquisition and analysis is performed automatically upon contact, and an audible signal informs the examiner the process is complete. The images are saved internally and can be wirelessly transmitted to a nearby computer for visualization and archival storage. Once the end user realizes the value of this product, concerns regarding corneal contact will dissipate, and this new camera will replace the direct ophthalmoscope with 21st century technology. This Phase II program is aimed at developing optical, mechanical, electronic and image analysis aspects of the camera, which must conform to a number of demanding performance and miniaturization specifications. The outcome of this project will be several clinically tested commercial prototypes, which can be exhibited to potential investors and customers, such as large ophthalmic companies or end users. It will serve as the basis in Phase III for high-volume manufacturing process development, registration studies, and launch.
PUBLIC HEALTH RELEVANCE: The proposed ultra-portable hand-held wireless fundus camera provides an effective and simple approach to inspecting the human retina and documenting the findings. It replaces the direct ophthalmoscope as a more reliable and advanced medical device. The images can be collected during routine visits to primary care providers or specialists and in other high volume settings thereby reducing rates of vision loss and lowering health care costs, and improving the quality of life for millions of people.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Compact, cost-effective, and operator-friendly fundus camera for early detection
-
批准号:8913390
-
项目类别:
-
资助金额:$2.5万
-
财政年份:2010
-
负责人:Filipp Ignatovich
-
依托单位:
Compact, cost-effective, and operator-friendly fundus camera for early detection
-
批准号:7908515
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2010
-
负责人:Filipp Ignatovich
-
依托单位:
Compact, cost-effective, and operator-friendly fundus camera for early detection
-
批准号:8549252
-
项目类别:
-
资助金额:$47.94万
-
财政年份:2010
-
负责人:Filipp Ignatovich
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: